0001593968-20-000375.txt : 20200210 0001593968-20-000375.hdr.sgml : 20200210 20200210170201 ACCESSION NUMBER: 0001593968-20-000375 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200206 FILED AS OF DATE: 20200210 DATE AS OF CHANGE: 20200210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MICHEL GERARD J CENTRAL INDEX KEY: 0001235644 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35280 FILM NUMBER: 20592796 MAIL ADDRESS: STREET 1: 420 CHIPETA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vericel Corp CENTRAL INDEX KEY: 0000887359 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943096597 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 7349305555 MAIL ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC DATE OF NAME CHANGE: 19960428 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2020-02-06 0000887359 Vericel Corp VCEL 0001235644 MICHEL GERARD J C/O VERICEL CORPORATION 64 SIDNEY STREET CAMBRIDGE MA 02139 false true false false CFO and VP, Corp. Development Common Stock 2020-02-06 4 M false 3000 0 A 162732 D Common Stock 2020-02-06 4 F false 1460 17.28 D 161272 D Restricted Stock Unit 2020-02-06 4 M false 3000 17.28 D Common Stock 3000 9000 D The shares of common stock were acquired by the Reporting person as a result of the vesting of RSUs granted to the Reporting Person on February 6, 2019. The remaining RSUs will vest in annual installments on February 6, 2021, February 6, 2022, and February 6, 2023, respectively. These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of Restricted Stock Units. Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 6, 2019. The remaining RSUs will vest in annual installments on February 6, 2021, February 6, 2022, and February 6, 2023, respectively. No expiration date for this type of award. /s/ Gerard Michel 2020-02-10